vs
Side-by-side financial comparison of ASHFORD HOSPITALITY TRUST INC (AHT) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $259.0M, roughly 1.3× ASHFORD HOSPITALITY TRUST INC). HAEMONETICS CORP runs the higher net margin — 13.2% vs -26.8%, a 40.0% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (-2.7% vs -6.0%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $-86.8M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (0.4% CAGR vs -7.7%).
Ashford Hospitality Trust Inc is a U.S.-headquartered real estate investment trust focused on upper-upscale full-service hotel properties across key U.S. urban, suburban and resort markets. Its portfolio holds assets under top global hospitality brands, serving business and leisure travelers, with a focus on long-term value growth and stable shareholder returns.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
AHT vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $259.0M | $339.0M |
| Net Profit | $-69.3M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | -2.6% | 19.9% |
| Net Margin | -26.8% | 13.2% |
| Revenue YoY | -6.0% | -2.7% |
| Net Profit YoY | 44.2% | 19.3% |
| EPS (diluted) | $-12.85 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $259.0M | $339.0M | ||
| Q3 25 | $266.1M | $327.3M | ||
| Q2 25 | $302.0M | $321.4M | ||
| Q1 25 | $277.4M | $330.6M | ||
| Q4 24 | $275.5M | $348.5M | ||
| Q3 24 | $276.6M | $345.5M | ||
| Q2 24 | $316.5M | $336.2M | ||
| Q1 24 | $303.9M | — |
| Q4 25 | $-69.3M | $44.7M | ||
| Q3 25 | $-60.1M | $38.7M | ||
| Q2 25 | $-30.4M | $34.0M | ||
| Q1 25 | $-20.0M | $58.0M | ||
| Q4 24 | $-124.2M | $37.5M | ||
| Q3 24 | $-57.9M | $33.8M | ||
| Q2 24 | $50.3M | $38.4M | ||
| Q1 24 | $71.6M | — |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | — |
| Q4 25 | -2.6% | 19.9% | ||
| Q3 25 | 4.6% | 17.9% | ||
| Q2 25 | 16.3% | 16.8% | ||
| Q1 25 | 22.2% | 21.6% | ||
| Q4 24 | -17.8% | 16.9% | ||
| Q3 24 | 7.3% | 15.0% | ||
| Q2 24 | 42.8% | 11.8% | ||
| Q1 24 | 50.2% | — |
| Q4 25 | -26.8% | 13.2% | ||
| Q3 25 | -22.6% | 11.8% | ||
| Q2 25 | -10.1% | 10.6% | ||
| Q1 25 | -7.2% | 17.5% | ||
| Q4 24 | -45.1% | 10.8% | ||
| Q3 24 | -20.9% | 9.8% | ||
| Q2 24 | 15.9% | 11.4% | ||
| Q1 24 | 23.5% | — |
| Q4 25 | $-12.85 | $0.95 | ||
| Q3 25 | $-11.35 | $0.81 | ||
| Q2 25 | $-6.88 | $0.70 | ||
| Q1 25 | $-4.91 | $1.17 | ||
| Q4 24 | $-13.64 | $0.74 | ||
| Q3 24 | $-12.39 | $0.66 | ||
| Q2 24 | $2.50 | $0.74 | ||
| Q1 24 | $5.99 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.1M | $363.4M |
| Total DebtLower is stronger | $2.5B | $1.2B |
| Stockholders' EquityBook value | $-626.4M | $911.5M |
| Total Assets | $2.8B | $2.5B |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.1M | $363.4M | ||
| Q3 25 | $81.9M | $296.4M | ||
| Q2 25 | $100.0M | $292.9M | ||
| Q1 25 | $85.8M | $306.8M | ||
| Q4 24 | $112.9M | $320.8M | ||
| Q3 24 | $119.7M | $299.3M | ||
| Q2 24 | $121.8M | $344.4M | ||
| Q1 24 | $111.1M | — |
| Q4 25 | $2.5B | $1.2B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.7B | $1.2B | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.9B | — |
| Q4 25 | $-626.4M | $911.5M | ||
| Q3 25 | $-548.7M | $849.2M | ||
| Q2 25 | $-485.5M | $882.3M | ||
| Q1 25 | $-446.1M | $820.8M | ||
| Q4 24 | $-419.2M | $906.9M | ||
| Q3 24 | $-288.4M | $878.9M | ||
| Q2 24 | $-225.9M | $905.4M | ||
| Q1 24 | $-276.8M | — |
| Q4 25 | $2.8B | $2.5B | ||
| Q3 25 | $3.0B | $2.4B | ||
| Q2 25 | $3.1B | $2.5B | ||
| Q1 25 | $3.1B | $2.5B | ||
| Q4 24 | $3.2B | $2.5B | ||
| Q3 24 | $3.3B | $2.5B | ||
| Q2 24 | $3.3B | $2.5B | ||
| Q1 24 | $3.5B | — |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $93.6M |
| Free Cash FlowOCF − Capex | $-86.8M | $87.2M |
| FCF MarginFCF / Revenue | -33.5% | 25.7% |
| Capex IntensityCapex / Revenue | 27.5% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $-135.5M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.7M | $93.6M | ||
| Q3 25 | $5.5M | $111.3M | ||
| Q2 25 | $16.3M | $17.4M | ||
| Q1 25 | $-25.0M | $116.6M | ||
| Q4 24 | $-23.6M | $43.8M | ||
| Q3 24 | $795.0K | $48.8M | ||
| Q2 24 | $8.0M | $-27.4M | ||
| Q1 24 | $-46.5M | — |
| Q4 25 | $-86.8M | $87.2M | ||
| Q3 25 | $-226.0K | $106.3M | ||
| Q2 25 | $-3.6M | $13.6M | ||
| Q1 25 | $-44.8M | $100.9M | ||
| Q4 24 | $-131.6M | $35.2M | ||
| Q3 24 | $-21.8M | $39.4M | ||
| Q2 24 | $-22.9M | $-33.1M | ||
| Q1 24 | $-80.4M | — |
| Q4 25 | -33.5% | 25.7% | ||
| Q3 25 | -0.1% | 32.5% | ||
| Q2 25 | -1.2% | 4.2% | ||
| Q1 25 | -16.2% | 30.5% | ||
| Q4 24 | -47.8% | 10.1% | ||
| Q3 24 | -7.9% | 11.4% | ||
| Q2 24 | -7.2% | -9.8% | ||
| Q1 24 | -26.5% | — |
| Q4 25 | 27.5% | 1.9% | ||
| Q3 25 | 2.1% | 1.5% | ||
| Q2 25 | 6.6% | 1.2% | ||
| Q1 25 | 7.2% | 4.7% | ||
| Q4 24 | 39.2% | 2.5% | ||
| Q3 24 | 8.2% | 2.7% | ||
| Q2 24 | 9.8% | 1.7% | ||
| Q1 24 | 11.2% | — |
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | 0.16× | -0.71× | ||
| Q1 24 | -0.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHT
| Occupancy | $190.2M | 73% |
| Food And Beverage | $51.8M | 20% |
| Hotel Other | $16.6M | 6% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
